Search results
1 day ago · Market Value in 2023. US$ 16.5 Bn Market Value Forecast by 2034. US$ 42.9 Bn Growth Rate . 9.1% Historical Data . 2016 – 2022 Base Year . 2023 Forecast Data
1 day ago · Orthocell Ltd (ASX:OCC, OTC:ORHHF) has delivered record revenue for the June quarter and for the 2024 financial year as it experiences continuing impressive sales growth of its market-leading medical devices, Striate+™ and Remplir™. For the quarter, Orthocell achieved revenue of A$1.84 million ...
1 day ago · 0.57%. LEWISVILLE, Texas - Orthofix (NASDAQ: OFIX) Medical Inc. (NASDAQ:OFIX), a global medical device company, announced the U.S. Food and Drug Administration (FDA) 510 (k) clearance and the first U.S. implant of its Fitbone™ Transport and Lengthening System. The device, unique in its kind, is designed to treat large bone defects in the ...
1 day ago · Shalby Limited agreed to acquire an 14.06% minority stake in Pk Healthcare Private Limited on January 18, 2024. Presentation Operator MessageOperator Ladies and gentlemen, good day, and welcome to the Q1 FY '25 earnings Shalby Limited Conference Call hosted by Elara Securities Private Limited.
1 day ago · Pricing & Comparison Chart ... Usability (Disposable, Reusable), Application (General Surgery, Neurosurgery, Orthopedic, Cardiovascular, Dental), End User - Global Forecast to 2029 " report ...
1 day ago · WILMINGTON, DE, July 9, 2024 - Enovis™ Corporation , an innovation-driven medical technology growth company, announced today that its DJO, LLC subsidiary will showcase two of its newest braces-the...
1 day ago · The global hydroxyapatite market was valued at USD 2.98 billion in 2021 and is projected to reach USD 4.5 billion by 2030, growing at a CAGR of 5.6% from 2022 to 2030. The market growth is driven by increasing consumer awareness regarding bioactive ceramics, rising healthcare expenditure worldwide ...
